International Journal of Infectious Diseases
Volume 13, Issue 6 , Pages e420-e423 , November 2009

Disseminated bacille Calmette–Guérin in Iranian children with severe combined immunodeficiency

  • Mahnaz Sadeghi-Shabestari

      Affiliations

    • Division of Pediatric Immunology and Allergy, Children's Hospital, Tabriz University (Medical Sciences), Tabriz, Iran
    • Corresponding Author InformationCorresponding author. Tel.: +98 411 334 0533; fax: +98 411 526 2280.
    • ,
  • Nima Rezaei

      Affiliations

    • Growth and Development Research Center, Center of Excellence for Pediatrics, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran

Received 10 February 2008 ,Revised 7 October 2008 ,Accepted 13 February 2009.

References 

  1. Casanova JL, Jouanguy E, Lamhamedi S, Blanche S, Fischer A. Immunological conditions of children with BCG disseminated infection. Lancet. 1995;346:581
  2. Cohn DL. Use of the bacille Calmette–Guérin vaccination for the prevention of tuberculosis: renewed interest in an old vaccine. Am J Med Sci. 1997;313:372–376
  3. Gonzalez B, Moreno S, Burdach R, Valenzuela MT, Henriquez A, Ramos MI, et al. Clinical presentation of Bacillus Calmette–Guérin infections in patients with immunodeficiency syndromes. Pediatr Infect Dis J. 1989;8:201–206
  4. Casanova JL, Blanche S, Emile JF, Jouanguy E, Lamhamedi S, Altare F, et al. Idiopathic disseminated bacillus Calmette–Guérin infection: a French national retrospective study. Pediatrics. 1996;98:774–778
  5. Afshar Paiman S, Siadati A, Mamishi S, Tabatabaie P, Khotaee G. Disseminated Mycobacterium bovis infection after BCG vaccination. Iran J Allergy Asthma Immunol. 2006;5:133–137
  6. Deeks SL, Clark M, Scheifele DW, Law BJ, Dawar M, Ahmadipour N, et al. Serious adverse events associated with bacille Calmette–Guérin vaccine in Canada. Pediatr Infect Dis J. 2005;24:538–541
  7. Geha RS, Notarangelo L, Casanova JL, Chapel H, Fischer A, Hammarstrom L, et al. Primary immunodeficiency diseases: an update the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. J Allergy Clin Immunol. 2007;120:776–794
  8. Rezaei N, Aghamohammadi A, Moin M, Pourpak Z, Movahedi M, Gharagozlou M, et al. Frequency and clinical manifestations of patients with primary immunodeficiency disorders in Iran: update from the Iranian Primary Immunodeficiency Registry. J Clin Immunol. 2006;26:519–532
  9. Huang LH, Shyur SD, Weng JD, Shin-Chi , Huang FY, Tzen CY. Disseminated cutaneous bacille Calmette–Guérin infection identified by polymerase chain reaction in a patient with X-linked severe combined immunodeficiency. Pediatr Dermatol. 2006;23:560–563
  10. Yeganeh M, Heidarzade M, Pourpak Z, Parvaneh N, Rezaei N, Aghamohammadi A, et al. Severe combined immunodeficiency: a cohort of forty patients. Pediatr Allergy Immunol. 2008;19:303–306
  11. Movahedi M, Aghamohammadi A, Rezaei N, Shahnavaz N, Jandaghi AB, Farhoudi A, et al. Chronic granulomatous disease: a clinical survey of 41 patients from the Iranian primary immunodeficiency registry. Int Arch Allergy Immunol. 2004;134:253–259
  12. Bustamante J, Aksu G, Vogt G, de Beaucoudrey L, Genel F, Chapgier A, et al. BCG-osis and tuberculosis in a child with chronic granulomatous disease. J Allergy Clin Immunol. 2007;120:32–38
  13. Reichenbach J, Rosenzweig S, Doffinger R, Dupuis S, Holland SM, Casanova JL. Mycobacterial diseases in primary immunodeficiencies. Curr Opin Allergy Clin Immunol. 2001;1:503–511
  14. Filipe Santos O, Bustamante J, Chapgier A, Vogt G, de Beaucoudrey L, Feinberg J, et al. Inborn errors of the IL-12/23 and IFN-gamma mediated immunity: molecular, cellular and clinical features. Semin Immunol. 2006;18:347–361
  15. Moin M, Farhoudi A, Movahedi M, Rezaei N, Pourpak Z, Yeganeh M. The clinical and laboratory survey of Iranian patients with hyper-IgE syndrome. Scand J Infect Dis. 2006;38:898–903
  16. Rezaei N, Pourpak Z, Aghamohammadi A, Farhoudi A, Movahedi M, Gharagozlou M, et al. Consanguinity in primary immunodeficiency disorders; the report from Iranian primary immunodeficiency registry. Am J Reprod Immunol. 2006;56:145–151
  17. Stephan JL, Vlekova V, Le Deist F, Blanche S, Donadieu J, De Saint-Basile G, et al. Severe combined immunodeficiency: a retrospective single-center study of clinical presentation and outcome in 117 patients. J Pediatr. 1993;123:564–572
  18. Abramowsky C, Gonzalez B, Sorensen RU. Disseminated bacillus Calmette–Guérin infections in patients with primary immunodeficiencies. Am J Clin Pathol. 1993;100:52–56
  19. Global tuberculosis control. World Health Organization reports 1996-2002. TB situation in the region: Islamic Republic of Iran. Presented at the Meeting of National Managers of the Tuberculosis Control Programmes in the Eastern Mediterranean Region, Rabat, June 17-19, 2003.
  20. Khazaei HA, Rezaei N, Bagheri GR, Dankoub MA, Shahryari K, Tahai A, et al. Epidemiology of tuberculosis in the southeastern Iran. Eur J Epidemiol. 2005;20:879–883
  21. Barreto ML, Pereira SM, Ferreira AA. BCG vaccine: efficacy and indications for vaccination and revaccination. J Pediatr (Rio J). 2006;82:45–54
  22. Sadeghi Shabestari M, Maljaei SH, Baradaran R, Barzegar M, Hashemi F, Mesri A, et al. Distribution of primary immunodeficiency diseases in the Turk ethnic group, living in the northwestern Iran. J Clin Immunol. 2007;27:510–516

PII: S1201-9712(09)00100-3

doi: 10.1016/j.ijid.2009.02.008

International Journal of Infectious Diseases
Volume 13, Issue 6 , Pages e420-e423 , November 2009

Article Tools

* Image Usage & Resolution